VERSAFITCUP DM DOUBLE MOBILITY HC LINER Ø 52/28
Report
- Report Number
- 3005180920-2023-00621
- Event Type
- Injury
- Date Received
- August 2, 2023
- Date of Event
- July 12, 2023
- Report Date
- August 2, 2023
- Manufacturer
- MEDACTA INTERNATIONAL SA
- Product Code
- MEH
- UDI-DI
- 07630030807343
- PMA / PMN Number
- K092265
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- MO, US
- Reporter Occupation
- 003
Narratives
BATCH REVIEW PERFORMED ON (B)(6) 2023. LOT 2245579: (B)(4) ITEMS MANUFACTURED AND RELEASED ON03-JAN-2023. EXPIRATION DATE: 2027-12-13. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. ADDITIONAL IMPLANTS INVOLVED, BATCH REVIEW PERFORMED ON (B)(6) 2023: BALL HEADS: MECTACER 01.29.203 BIOLOX DELTA CERAMIC BALL HEAD 12/14 Ø 28 SIZE L +3.5 (K112115) LOT. 2249522: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 25-JAN-2023. EXPIRATION DATE: 2028-01-04. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW. AMISTEM-P COLLARED 01.18.432 AMISTEM-P COLLARED STD STEM SIZE 2 (K173794) LOT. 2242521: (B)(4) ITEMS MANUFACTURED AND RELEASED ON 17-FEB-2023. EXPIRATION DATE: 2028-02-01. NO ANOMALIES FOUND RELATED TO THE PROBLEM. TO DATE, (B)(4) ITEMS OF THE SAME LOT HAVE BEEN SOLD WITH NO SIMILAR REPORTED CASE DURING THE PERIOD OF REVIEW.
AT ABOUT 1 MONTH AFTER THE PRIMARY, THE PATIENT CAME IN DUE TO SIGNS OF AN INFECTION AND THE PATHOGEN IS UNKNOWN. THE SURGEON PERFORMED A WASHOUT, REMOVED THE STEM, HEAD AND LINER, AND IMPLANTED AN ANTIBIOTIC SPACER. THE SURGERY WAS COMPLETED SUCCESSFULLY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 797005 | VERSAFITCUP DM DOUBLE MOBILITY HC LINER Ø 52/28 | HIP DOUBLE MOBILITY LINER | MEH | MEDACTA INTERNATIONAL SA | 2245579 | 07630030807343 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | Female | Required Intervention |